<DOC>
	<DOCNO>NCT00837941</DOCNO>
	<brief_summary>The purpose study determine analgesic efficacy detect single dose administration patient chronic neuropathic pain due painful diabetic neuropathy .</brief_summary>
	<brief_title>A Study Single Dose Pain Therapy Patients With Painful Diabetic Neuropathy ( 0000-115 )</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patient treat type 1 2 diabetes mellitus glycosylated hemoglobin Patient pain foot occur onset diabetes Patient agrees maintain consistent activity level throughout study Patient chronic pain therapy , stable dose one pain therapy Female patient reproductive potential must agree use two acceptable method birth control study Patients take pain medication must stable dose least 1 month prior participate study Patient history congestive heart failure Patient has/had seizure disorder Patient try fail 3 drug treat neuropathic pain Patient currently take pregabalin duloxetine hydrochloride Patient malignancy within past 2 year ( exclude basal cell carcinoma ) Patient history hepatitis B C HIV infection Patient skincondition may decrease sensitivity area neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>